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The present study extends previous research by exploring the predictive value of beliefs about insulin therapy in fear
of hypoglycaemia (FoH). Data were collected on 81 Spanish adults (aged 18–58 years) with type 1 diabetes.
Participants completed a survey questionnaire containing the following measures: state-trait anxiety inventory
(STAI), beliefs about medicines questionnaire (specific scale), a modified version of the FoH Survey (worry scale)
and different questions about demographic and clinical information (duration of diabetes, daily shots of insulin,
severe hypoglycaemic episodes, metabolic control). Regression analyses showed that history of severe hypogly-
caemic episodes and concerns about insulin therapy had the most predictive influence on FoH. Treatment
perceptions, particularly concerns about insulin, were related to reported FoH. However, FoH is a complex
phenomenon and more research is needed in order to gain a better understanding of its predictors and correlates.
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INTRODUCTION
Hypoglycaemia or insulin reaction (low
blood glucose) is the most significant acute
complication of type 1 diabetes, particularly
during intensive insulin treatments.1
Symptoms of hypoglycaemia include weak-
ness, hunger, dizziness, mental confusion,
pounding heart, irritability, trembling and
sweating. Severe hypoglycaemia can lead to
loss of consciousness, coma and potential
death. Consequently, insulin reaction repre-
sents one of the patient’s greatest fears.
Two key components or dimensions of fear
of hypoglycaemia (FoH) have been identi-
fied: specific worries associated with insulin
reaction and the different behaviours to avoid
hypoglycaemia. The Hypoglycaemic Fear
Survey (HFS)2 is the most widely used
instrument for examining FoH in adults
and includes two subscales assessing Worry
and Behaviour. Previous studies have found
that factors such as trait anxiety and past
hypoglycaemic episodes are significant predic-
tors of FoH.3,4 At the same time, some
research has suggested that FoH might pro-
mote non-adherence behaviours in order to
avoid hypoglycaemia, which in turn would
affect metabolic control.2 However, other
studies have found that individuals with
well-controlled diabetes had the highest
levels of FoH.4
Apart from personality factors, such as
trait anxiety, it would be interesting to iden-
tify other more specific and proximal psy-
chological factors as predictors of FoH.
Research has found that patients’ beliefs
about treatment, and associated emotional
responses, can have an important influence
on their decisions about treatment andReprint requests to: Marina Bele´ndez.
Email: marina.belendez@ua.es
 The Author(s), 2009. Reprints and permissions:
http://www.sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1742395309346464
XML Template (2009) [17.9.2009–5:51pm] [1–7]
K:/CHI/CHI 346464.3d (CHI) [INVALID Stage]
illness outcomes. In this way, people’s views
about treatment (perceived necessity and
concerns) have been identified as strong
predictors of treatment adherence.5
Although the majority of people with dia-
betes, particularly those with type 1 diabetes,
agree that insulin therapy is essential for their
health, a percentage of them express con-
cerns about potential adverse effects asso-
ciated with taking insulin.6 However, little is
known about the potential links between
treatment beliefs, especially concerns about
insulin therapy, and FoH.
The present study extends previous
research by exploring the predictive value of
concerns about insulin taking on FoH. The
primary purpose of this study is to evaluate
the specific influence of concerns about
insulin on FoH after controlling the contri-
bution of personality, such as trait anxiety,
and situational factors, such as past negative
experience with hypoglycaemia. It is pre-
dicted that higher levels of concerns about
insulin therapy will be related to higher level
of FoH. In addition, a further aim is to
explore the relationships between FoH,
treatment adherence and metabolic control.
METHOD
Sample and Measures
Data were collected on 81 adults, 56%
females, (aged 18–58 years, M¼ 30.2
years) with type 1 diabetes recruited from
one hospital and several patients associations
located in Spain. Participants completed a
survey questionnaire containing the follow-
ing measures:
The State-Trait Anxiety Inventory (STAI),
Trait Subscale,7 a measure of anxiety asses-
sing the trait of anxiety proneness which is
made up of 20 items asking participants to
indicate how they usually feel on a 4-point
Likert scale (0¼never to 3¼ always). The
internal consistency (Cronbach’s alpha) for
the subscale in the present study was 0.88.
The Beliefs about Medicines Questionnaire
(BMQ)-Specific,8 which comprises two
scales assessing beliefs about the ‘necessity’
of the insulin (e.g. ‘My health at present
depends on my medicines’) and the ‘con-
cerns’ about taking it (e.g. ‘Having to take
my medicines worries me’). Participants are
required to indicate the extent they agree or
disagree with each statement, using a 5-point
Likert-type scale (where 1¼ strongly dis-
agree; 5¼ strongly agree). The internal
consistency (Cronbach’s alpha) for the
BMQ-scales in the present study were 0.74
(concerns) and 0.65 (necessity).
The Fear of Hypoglycaemia Survey (Worry
Scale)2 (adapted from Cox et al.2). Eight
items that assess the degree of worry
(0¼never; 4¼many times) about hypogly-
caemic episodes (e.g. ‘I worry about having a
hypoglycaemia while sleeping’, ‘I worry
about having a hypoglycaemia when respon-
sible for others’). The current research found
a high internal consistency (Cronbach’s
alpha): 0.88.
Frequency of hypoglycaemic episodes experi-
enced in the previous 12 months (never¼ 0
to daily¼ 5).
Severe hypoglycaemic episodes in the previ-
ous 12 months (requiring external assis-
tance): yes/no.
Treatment adherence: Four items to assess
the frequency of performing diabetes self-
care tasks adapted from previous studies:9
diet (two items: ‘Some people don’t follow
their dietary recommendations – e.g., eat
high fat foods, skip meals, how often does
this happen to you?’, ‘Some people eat
sweets and desserts. How often does this
happen to you?’; never¼ 4 to very often¼0),
insulin taking (one item: ‘Some people don’t
take their insulin injections that they are
supposed to. How often does this happen to
you?’; never¼4 to very often¼ 0) and glu-
cose monitoring (one item: How often do
you test your glucose levels? 0¼never to
4¼ three or more times a day), with higher
scores indicating higher adherence. The
internal consistency (Cronbach’s alpha) for
this scale was 0.65.
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Metabolic control was calculated using
levels of glycosylated haemoglobin
(HbA1c), a retrospective measure of average
blood glucose during the previous 2–3
months, with higher levels reflecting poorer
control (good metabolic control: 57%).
HbA1c values were obtained from medical
records.
RESULTS
Intercorrelations and scales descriptives
of the research variables are presented in
Table 1. The mean score of FoH (worry
scale) illustrates that participants in this
study reported levels of fear close to the
midpoint of the scale (M¼ 1.86, SD¼ 0.9).
About one-third of the sample reported
being worried about developing hypoglycae-
mia. The percentage of participants endor-
sing (often or many times) some of the items
representing FoH was as follows: 53.3% of
participants were worried about having a
hypoglycaemia when responsible for others,
48.1% about having a hypoglycaemia while
sleeping, 33.8% were worried about suffer-
ing a hypoglycaemia in public, 32.5% were
worried about having a hypoglycaemia while
alone or 31.2% were worried about not
recognizing hypoglycaemia symptoms.
Hypoglycaemic episodes were frequent.
More than a half of participants reported to
experience hypoglycaemia, at least, once a
week. Also, as expected, participants with a
more intensive treatment (more injections
and more frequency of glucose monitoring)
reported more frequency of hypoglycaemic
episodes. However, only a total of 13 parti-
cipants (16% of the study population)
reported a severe hypoglycaemic episode
(requiring external assistance) during the
last year. The mean scores for the BMQ
scales illustrated that, as expected, ‘neces-
sity’ scores were higher than ‘concerns’
about insulin. However, about 25% had
higher than mid-point scores on the ‘con-
cerns’ scale.
FoH: Predictors
As can be seen in Table 1, there were
significant positive relationships between
FoH, concerns about insulin (r¼ 0.38,
p50.01), trait anxiety (r¼ 0.33, p50.01)
and experience of severe hypoglycaemic
events (r¼ 0.27, p50.05). In this respect,
those participants who reported severe hypo-
glycaemia expressed higher levels of FoH
(M¼ 2.41, SD¼ 0.81) when compared with
individuals who did not report episodes of
severe hypoglycaemia (M¼ 1.74, SD¼ 0.92;
p¼ 0.018). However, FoH and frequency of
hypoglycaemic episodes in the previous year
were not correlated.
A two-step hierarchicalmultiple regression
analysis was used to assess the amount of
variance in FoH that could be explained by
concerns about taking insulin, once the effect
situational variables (past experience of
severe hypoglycaemic events) and personal-
ity factors (trait anxiety) were accounted for
(Table 2). Analysis showed that past experi-
ence of severe hypoglycaemic episodes
(¼0.25, p50.05) and trait anxiety
(¼0.32, p50.01) in the first step
accounted for 17% of the variance. In the
second step, the entry of concerns about
insulin explained an additional 9% of the
variance in FoH with past experience of
severe hypoglycaemic events (¼ 0.29,
p50.01) and concerns about insulin
(¼0.33, p50.01) accounting for unique
variance in FoH. Thus, trait anxiety,
although correlating with FoH, was not
found to be a significant predictor when
entered together with the rest of variables.
This is suggestive that concerns about insulin
might be a mediating variable between trait
anxiety and FoH.
Following Baron and Kenny10 four con-
ditions are necessary in order to establish
mediation: (a) a significant association
between predictor (trait anxiety) and out-
come variable (FoH), (b) a significant rela-
tionship between predictor (trait anxiety)
and presumed mediator (concerns about
insulin), (c) a significant association between
presumed mediator (concerns about insulin)
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and outcome variable (FoH) and (d) the
previously significant relation between pre-
dictor (trait anxiety) and outcome variable
(FoH) is no longer significant (full media-
tion) or diminishes (partial mediation) when
the presumed mediator (concerns about
insulin) is controlled. On this basis, four
separate regression analyses were conducted.
First, a simple regression analysis with trait
anxiety predicting FoH (¼ 0.33, p50.01),
second, with trait anxiety predicting con-
cerns about insulin (¼ 0.39, p50.001),
third, with concerns about insulin predicting
FoH (¼ 0.38, p50.01), and finally, a mul-
tiple regression analysis with trait anxiety
predicting FoH and controlling the influence
of concerns about insulin. In this final step
the effect of concerns about insulin remained
significant (*¼ 0.30, p50.01) and the
regression weight for trait anxiety dimin-
ished (*¼ 0.22, p¼ 0.052). Therefore, the
conditions were met and concerns about
insulin partially mediated the relationship
between trait anxiety and FoH.
The regression analyses performed are
depicted in the Fig.
Relationships between FoH, Adherence
and Metabolic Control
Most of participants reported a high level of
adherence to insulin and medium levels of
frequency of performing diabetes care tasks
such as blood glucose testing or avoidance of
inappropriate foods. There were not signifi-
cant correlations between FoH and diabetes
self-care tasks (adherence). However, as
expected, beliefs about the necessity of insu-
lin (very high in this population) were asso-
ciated to diabetes self-care tasks which, in
turn, were associated to better metabolic
control. Also, there was no relationship bet-
ween FoH and metabolic control (HbA1c
values). In addition, better metabolic control
(lowest HbA1c values) was associated with
frequency of hypoglycaemic episodes.
DISCUSSION
Although participants as a group reported
moderated levels of FoH more than half of
participants were worried about having
hypoglycaemia when responsible for others
and nearly half of them were worried about
having an insulin reaction while sleeping.
These findings reveal that FoH deserves
special consideration for researchers and
practitioners.
The primary purpose of this study was to
evaluate the specific influence of concerns
about insulin on FoH. The regression model
revealed the association between concerns
about insulin and FoH after controlling for
past history of severe hypoglycaemic
b=0.39, p<0.001
 b=0.38, p<0.01
b *=0.22, p<0.05
Fear of
hypoglycaemia
Concerns
about insulin 
b *=0.30, p<0.01
 b=0.33, p< 0.01
Trait anxiety
FIG. Concerns about insulin partly mediated the influence of trait anxiety on FoH.
TABLE 2. Summary of hierarchical regression analysis for
variables predicting FoH
DR2 B SE B 
Step 2 0.17
Severe hypoglycaemic
episodes
0.61 0.26 0.25*
Trait anxiety 0.59 0.20 0.32**
Step 2 0.09
Severe hypoglycaemic
episodes
0.71 0.25 0.29**
Trait anxiety 0.34 0.21 0.18
BMQ-Concerns 0.36 0.12 0.33**
Total R2¼ 0.27. F(3, 72)¼8.71, p50.001. *p50.05,
**p50.01.
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episodes and trait anxiety. These findings
suggest that concerns about insulin therapy
accounted for unique variance in FoH,
supporting our central hypothesis. Also,
consistent with previous research, our results
supported the hypothesis about the role of
past history of severe hypoglycaemic epi-
sodes as a significant predictor of FoH.11
Personality variables, such as trait anxiety,
have also been proposed in previous studies
as determinants in the development of FoH,4
In the present study trait anxiety, although
correlating with FoH, was not found to be a
significant predictor when entered together
with the rest of variables. In order to clarify
the role of trait anxiety in FoH we tested
whether the effect of trait anxiety on FoH
was mediated by concerns about insulin.
Mediational analysis revealed that anxiety
might be associated to FoH via its effects on
concerns about insulin.
We did not find a relationship between
frequency of hypoglycaemia and FoH.When
analysing the role of experience of hypogly-
caemia in explaining FoH it is the severity of
insulin reactions instead of its frequency the
main determinant on FoH. At the same time,
we found logical and interesting correlations
among our study variables. For example,
those people with more intensive treatments
(more daily injections and more frequency of
glucose testing) reported a higher number of
hypoglycaemic episodes and also had a better
metabolic control. This pattern of interrela-
tions supports the evidence in medical
research that intensifying treatment to lower
HbA1c values results in an increase in the
frequency of hypoglycaemia. Similarly, we
found that those participants who had dia-
betes longer reported lower levels of insulin-
related concerns. Perhaps more experience
with insulin therapy may be associated with a
higher level of knowledge about its effects
and lower level of concerns.
Regarding our secondary research ques-
tion we did not find a significant relationship
between FoH and adherence; also, there was
no relationship between FoH and metabolic
control. Although some previous research
has reported a negative impact of FoH on
diabetes control,12 other studies have failed
to find a relationship3 or have suggested that
the tighter the metabolic control (lower
HbA1c values) the greater the worry.13
Finally, this study also had several limita-
tions that should be considered. On one
hand, the sample size might limit the gener-
alization of the results. On the other poten-
tial limitation of the study refers to the
instruments to assess adherence or self-care
tasks. The use of self-report measures might
have overreported the levels of performance
of self-care tasks; however, about 30% of the
participants reported that they performed
less than one glucose test a day, which
indicates reliable and honest answers.
CONCLUSIONS
This exploratory study has shown that treat-
ment perceptions, particularly concerns about
insulin, and past history of severe hypogly-
caemic episodes were related to reported
FoH. Some practical implications may be
proposed. First, given the role of past history
of severe hypoglycaemia in FoH, it would be
appropriate to prevent these events in special
subgroups of patients who have problems to
detect early signs of insulin reactions. Also,
given the role of concerns about insulin in
FoH, it would be interesting to assess patients’
beliefs about treatment among specific groups,
for example, patients with type 2 who are
candidates to change to insulin therapy
because their therapy with oral agents has
failed to control diabetes. Likewise, as we
found that participants with a shorter dura-
tion of diabetes reported higher level of
concerns about insulin, it would be especially
recommended the assessment of their treat-
ment beliefs early after the diagnosis.
In summary, FoH is a complex phenom-
enon and more research is needed to under-
stand the interactions between its biological
and psychological determinants and its
impact on treatment adherence and meta-
bolic control.
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